موئکسی‌پریل (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "موئکسی‌پریل" in Persian language version.

refsWebsite

Global rank Persian rank

10nih.gov

4^th place

5^th place

8doi.org

2^nd place

2semanticscholar.org

11^th place

52^nd place

1archive.org

6^th place

9^th place

1espacenet.com

800^th place

2,283^rd place

1google.com

163^rd place

148^th place

archive.org

Hochadel, Maryanne, ed. (2006). The AARP Guide to Pills. Sterling Publishing Company. p. 640. ISBN 978-1-4027-1740-6. Retrieved 2009-10-09.

doi.org

Rosendorff, C (1996). "The renin-angiotensin system and vascular hypertrophy". Journal of the American College of Cardiology. 28 (4): 803–812. doi:10.1016/s0735-1097(96)00251-3. PMID 8837552.
Jaiswal N, Diz DI, Chappell MC, Khosia MC, Ferrario CM (1992). "Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors". Hypertension. 19 (2): 49–55. doi:10.1161/01.hyp.19.2_suppl.ii49. PMID 1735595.
Youn, T. J.; Kim, H. S.; Oh, B. H. (1999). "Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: Effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade". Basic Research in Cardiology. 94 (4): 246–253. doi:10.1007/s003950050149. PMID 10505424. S2CID 24853463.
Kalász, H; Petroianu, G; Tekes, K; Klebovich, I; Ludányi, K; Gulyás, Z (2007). "Metabolism of moexipril to moexiprilat: Determination of in vitro metabolism using HPLC-ES-MS". Medicinal Chemistry. 3 (1): 101–106. doi:10.2174/157340607779317490. PMID 17266629.
Cawello, W; Boekens, H; Waitzinger, J; Miller, U (2002). "Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition". International Journal of Clinical Pharmacology and Therapeutics. 40 (1): 9–17. doi:10.5414/cpp40009. PMID 11837383.
Chrysant, S. G. (1998). "Vascular remodeling: The role of angiotensin-converting enzyme inhibitors". American Heart Journal. 135 (2 Pt 2): 21–30. doi:10.1053/hj.1998.v135.86971. PMID 9488609.
Cameron, RT; Coleman, RG; Day, JP; Yalla, KC; Houslay, MD; Adams, DR; Shoichet, BK; Baillie, GS (May 2013). "Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)". Biochemical Pharmacology. 85 (9): 1297–1305. doi:10.1016/j.bcp.2013.02.026. PMC 3625111. PMID 23473803.
Klutchko, Sylvester; Blankley, C. John; Fleming, Robert W.; Hinkley, Jack M.; Werner, Ann E.; Nordin, Ivan; Holmes, Ann; Hoefle, Milton L.; Cohen, David M.; Essenburg, A. D. (1986). "Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types". Journal of Medicinal Chemistry. 29 (10): 1953–61. doi:10.1021/jm00160a026. PMID 3020249.

espacenet.com

v3.espacenet.com

EP 49605, Hoefle, Milton Louis & Sylvester Klutchko, "Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids, salts thereof, pharmaceutical compositions containing the derivatives or salts, and the production of the same", published 1982-04-14 ; M. L. Hoefle, S. Klutchko, U.S. Patent ۴٬۳۴۴٬۹۴۹

google.com

EP 49605, Hoefle, Milton Louis & Sylvester Klutchko, "Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids, salts thereof, pharmaceutical compositions containing the derivatives or salts, and the production of the same", published 1982-04-14 ; M. L. Hoefle, S. Klutchko, U.S. Patent ۴٬۳۴۴٬۹۴۹

nih.gov

pubmed.ncbi.nlm.nih.gov

White, W. B.; Stimpel, M (1995). "Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension". Journal of Human Hypertension. 9 (11): 879–884. PMID 8583466.
Rosendorff, C (1996). "The renin-angiotensin system and vascular hypertrophy". Journal of the American College of Cardiology. 28 (4): 803–812. doi:10.1016/s0735-1097(96)00251-3. PMID 8837552.
Jaiswal N, Diz DI, Chappell MC, Khosia MC, Ferrario CM (1992). "Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors". Hypertension. 19 (2): 49–55. doi:10.1161/01.hyp.19.2_suppl.ii49. PMID 1735595.
Youn, T. J.; Kim, H. S.; Oh, B. H. (1999). "Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: Effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade". Basic Research in Cardiology. 94 (4): 246–253. doi:10.1007/s003950050149. PMID 10505424. S2CID 24853463.
Kalász, H; Petroianu, G; Tekes, K; Klebovich, I; Ludányi, K; Gulyás, Z (2007). "Metabolism of moexipril to moexiprilat: Determination of in vitro metabolism using HPLC-ES-MS". Medicinal Chemistry. 3 (1): 101–106. doi:10.2174/157340607779317490. PMID 17266629.
Cawello, W; Boekens, H; Waitzinger, J; Miller, U (2002). "Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition". International Journal of Clinical Pharmacology and Therapeutics. 40 (1): 9–17. doi:10.5414/cpp40009. PMID 11837383.
Chrysant, S. G. (1998). "Vascular remodeling: The role of angiotensin-converting enzyme inhibitors". American Heart Journal. 135 (2 Pt 2): 21–30. doi:10.1053/hj.1998.v135.86971. PMID 9488609.
Cameron, RT; Coleman, RG; Day, JP; Yalla, KC; Houslay, MD; Adams, DR; Shoichet, BK; Baillie, GS (May 2013). "Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)". Biochemical Pharmacology. 85 (9): 1297–1305. doi:10.1016/j.bcp.2013.02.026. PMC 3625111. PMID 23473803.
Klutchko, Sylvester; Blankley, C. John; Fleming, Robert W.; Hinkley, Jack M.; Werner, Ann E.; Nordin, Ivan; Holmes, Ann; Hoefle, Milton L.; Cohen, David M.; Essenburg, A. D. (1986). "Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types". Journal of Medicinal Chemistry. 29 (10): 1953–61. doi:10.1021/jm00160a026. PMID 3020249.

ncbi.nlm.nih.gov

Cameron, RT; Coleman, RG; Day, JP; Yalla, KC; Houslay, MD; Adams, DR; Shoichet, BK; Baillie, GS (May 2013). "Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)". Biochemical Pharmacology. 85 (9): 1297–1305. doi:10.1016/j.bcp.2013.02.026. PMC 3625111. PMID 23473803.

semanticscholar.org

Youn, T. J.; Kim, H. S.; Oh, B. H. (1999). "Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: Effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade". Basic Research in Cardiology. 94 (4): 246–253. doi:10.1007/s003950050149. PMID 10505424. S2CID 24853463.

api.semanticscholar.org

Youn, T. J.; Kim, H. S.; Oh, B. H. (1999). "Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: Effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade". Basic Research in Cardiology. 94 (4): 246–253. doi:10.1007/s003950050149. PMID 10505424. S2CID 24853463.